CUV 1.80% $15.25 clinuvel pharmaceuticals limited

CUV Charting, page-87

  1. 1,090 Posts.
    lightbulb Created with Sketch. 472

    I sold out entirely, mainly due to dodgy market conditions and a little frustration with CUV sp. Maybe a foolish move, but Neuren is travelling along not too bad. Hoping to jump back over to Clinuvel early next year if conditions are favourable. Clinuvel has a lot on its plate coming up with XP and AIS so I expect lots of potential medium term. Investors have the luxury of two attractive biotechs to choose from in Neuren and CUV so a bet each way wouldn’t go astray either. It will come down to timing for me whether I can capitalise on both early next year.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.25
Change
-0.280(1.80%)
Mkt cap ! $763.6M
Open High Low Value Volume
$15.30 $15.59 $15.25 $507.0K 32.85K

Buyers (Bids)

No. Vol. Price($)
1 286 $15.24
 

Sellers (Offers)

Price($) Vol. No.
$15.43 165 1
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.